UZ Gent
Ghent, East Flanders, 9000, Belgium
Location status: Recruiting
NCT Number: NCT06294613
Prospective, interventional, open-label, non-controlled, monocentric study in Belgium of Luca, of up to 15 evaluable subjects, undergoing vitreoretinal surgery to treat intravitreal hemorrhage and macular pucker.
Only one eye per subject can be enrolled.
Interested in participating?
Request Info18 year–85 year
All sexes
Interventional
Not applicable
Ghent, East Flanders, 9000, Belgium
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients undergoing vitreoretinal surgery
Time frame: 3 Months
incidence and severity of investigational device-related (definitely or probably) adverse events, for all subjects treated with the study device (Safety Population).
Contact information is provided by the study sponsor or research team.
Acusurgical
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06429969
Vitreoretinal Disease
Wuhan, Hubei, China
View Trial DetailsNCT07298174
Age - Related Macular Degeneration (AMD), Best Disease
View Trial DetailsNCT06123923
Vitreoretinal Disease
Seoul, South Korea
View Trial DetailsNCT02477605
Vitreoretinal Disease
Fort Worth, Texas, United States
View Trial Details